ß-blocker drugs, especially the noncardioelective ones, are generally contraindicated in patients with asthma. In contrast, the risk-to-benefit ratio may be in favor of cardioselective beta-blockers in patients with COPD, especially those with a history of myocardial infarction (PMID 24277628). See under each specific beta-blocking agent

Last update : 24/04/2014
I - Interstitial/parenchymal lung disease
II - Pulmonary edema - Acute lung injury - ARDS
IV - Airway involvement
V - Pleural and/or pericardial involvement
VI - Pulmonary vasculopathies
IX - Neuromuscular / CNS involvement - Disordered breathing during sleep
X - Systemic/Distant conditions, syndromes and reactions
XI - Miscellaneous
XII - Cardiovascular involvement / toxicity